A Guide for Rapid Assessment of Antibodies Following Disclosure
OHSU # 2054
Antibodies are often developed as important tools during the course of fundamental and clinical research conducted at various universities and research institutions. These valuable reagents aid in research, diagnostics, and may be used as therapeutic agents. The global research antibody market is valued at $1.5B as of 2011 and is projected to grow at a rate of 2.9% over the following 5 years.
University Technology Managers are often tasked with evaluating antibody technologies to determine the field of use and distribution routes to get these reagents into the hands of appropriate end users. This guide is designed to aid Technology Managers rapidly identify key features of disclosed antibodies with the goal of determining the potential market and optimal distribution methods.
For more information, contact:
Technology Development Manager